These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 190870)

  • 1. Somatostatin: diabetes and acromegaly.
    Gerich JE
    Adv Intern Med; 1977; 22():251-72. PubMed ID: 190870
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin and the endocrine pancreas.
    Gerich JE
    Curr Top Mol Endocrinol; 1976; 3():127-43. PubMed ID: 211005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of growth hormone release inhibiting hormone (GH-RIH).
    Besser GM
    Curr Top Mol Endocrinol; 1976; 3():115-25. PubMed ID: 211004
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatostatin, basic and clinical studies. A review.
    Schally AV; Meyers CA
    Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin.
    Efendić S; Hökfelt T; Luft R
    Adv Metab Disord; 1978; 9():367-424. PubMed ID: 347908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Somatostatin--hormone inhibitor (author's transl)].
    Sieradzki J
    Przegl Lek; 1976; 33(3):393-7. PubMed ID: 1273332
    [No Abstract]   [Full Text] [Related]  

  • 7. [Somatostatin -- a review (author's transl)].
    Lucke C; Mitzkat HJ; von zur Mühlen A
    Klin Wochenschr; 1976 Apr; 54(7):293-301. PubMed ID: 1263405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin: physiological and clinical significance.
    Guillemin R; Gerich JE
    Annu Rev Med; 1976; 27():379-88. PubMed ID: 779605
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of somatostatin in the diabetic].
    Basdevant A
    Nouv Presse Med; 1977 Mar; 6(10):841-5. PubMed ID: 322089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].
    Lankosz-Lauterbach J
    Pediatr Pol; 1977 Aug; 52(8):919-23. PubMed ID: 333364
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
    Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
    Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin and diabetes.
    Gerich JE
    Am J Med; 1981 Mar; 70(3):619-26. PubMed ID: 6111219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin: a review of its effects especially in human beings.
    Hansen AP; Lundbaek K
    Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin].
    Guillemin R; Fontaine M
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(20):2353-6. PubMed ID: 807423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinetic analysis of plasma insulin disappearance and glucose-induced insulin delivery rate in diabetic and nondiabetic acromegalics.
    Maneschi F; Pilo A; Navalesi R
    Metabolism; 1979 Oct; 28(10):1011-22. PubMed ID: 491958
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of glucagon in human diabetic ketoacidosis: studies using somatostatin.
    Gerich JE; Schneider VS; Lorenzi M; Tsalikian E; Karam JH; Bier DM; Forsham PH
    Clin Endocrinol (Oxf); 1976; 5 Suppl():299S-305S. PubMed ID: 829924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in blood sugar, and insulin levels induced by somatostatin in normal, diabetic and acromegalic subjects].
    Carmina E; Lanzara P; Janní A
    Minerva Med; 1976 Apr; 67(18):1204-4-10. PubMed ID: 934480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma.
    Curnow RT; Carey RM; Taylor A; Johanson A; Murad F
    N Engl J Med; 1975 Jun; 292(26):1385-6. PubMed ID: 166308
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatostatin (growth hormone-release inhibiting hormone).
    Gomez-Pan A; Hall R
    Clin Endocrinol Metab; 1977 Mar; 6(1):181-200. PubMed ID: 196795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Somatostatin].
    Tragl KH
    Acta Med Austriaca; 1978; 5(3):80-4. PubMed ID: 377888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.